Dr. John

Co-founder & CEO, Cambridge Cancer Genomics


John is Co-founder and CEO at Cambridge Cancer Genomics (CCG.ai), a precision AI start-up transforming the ability of oncologists to finally provide effective, personalised cancer treatment for everyone. John holds a PhD in functional genomics from the University of Cambridge and a Masters in Pharmacology from the University of Glasgow. His research career in academia (CRUK) and industry (MedImmune) focused on understanding how tumours evolve and become resistant to treatment. John is actively involved in the biotech startup community as a Venture Partner at the Pioneer Fund, Director of SiliconBio and a lecturer at Anglia Ruskin University.

Back to speakers